Search - tctmd.com

Displaying 241 - 260 of 375

Sort: Relevancy | Date

News Daily News

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

Yael L. Maxwell

November 17, 2014

News Daily News

在SVG PCI中，DES显得安全、有效

Salynn Boyles

October 24, 2014

News Daily News

Los SLF Parecen Seguros y Efectivos para PCI en IVS

Salynn Boyles

October 24, 2014

News Daily News

DES Appear Safe and Effective in SVG PCI

Salynn Boyles

October 24, 2014

News Daily News

得到的FDA专家组支持率低，Watchman可能为时不多了

L.A. McKeown

October 16, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Daily News

Registry Study: Survival Benefit for Treating CTO After Primary PCI

Todd Neale

October 10, 2014

News Daily News

Registry Study: Survival Benefit for Treating CTO After Primary PCI登记处研究：在首次PCI后治疗CTO可带来生存率益处

Todd Neale

October 10, 2014

News Daily News

Estudio de Registro: Beneficio de Supervivencia para Tratar OTC Post-PCI Primarias

Todd Neale

October 10, 2014

Presentation TCT 2014

Case Presentation: I Wish I Had Gone Femoral!

Presenter: Olivier F. Bertrand, Philippe Généreux, David E. Kandzari, Robert J. Applegate

September 16, 2014

Presentation TCT 2014

Case Presentation: I Wish I Had Gone Radial!

Presenter: Olivier F. Bertrand, Philippe Généreux, David E. Kandzari, Douglas E. Drachman

September 16, 2014

Presentation TCT 2014

My Worst Radial Case Last Year and What I Learned

Presenter: Olivier F. Bertrand, Philippe Généreux, David E. Kandzari, Yves R. Louvard

September 16, 2014

Presentation TCT 2014

My Best Radial Case Last Year and What I Learned

Presenter: Olivier F. Bertrand, Philippe Généreux, David E. Kandzari, Tejas Patel

September 16, 2014

Presentation TCT 2014

Transradial Primary PCI in STEMI: Benefits, Mechanisms, and Practical Issues

Presenter: Olivier F. Bertrand, Yves R. Louvard, Herbert D. Aronow, David E. Kandzari

September 16, 2014

Presentation TCT 2014

Left Main Coronary Artery Disease: Pathology, Pathophysiology, and Clinical Presentation

Presenter: Jean Fajadet, Marie-Claude Morice, Margaret B. McEntegart, David E. Kandzari

September 16, 2014

Presentation TCT 2014

TCT 576: Primary Endpoint Results From the PROMUS Element Plus US Postapproval Study (PE-Plus PAS): 1-Year Outcomes in Real-World Patients Treated with a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent

Presenter: John M. Lasala, Stuart J. Pocock, David E. Kandzari

September 16, 2014

Presentation TCT 2014

Second Deep Dive into SYMPLICITY HTN-3: Novel Mechanistic Insights from the Trial

Presenter: David Kandzari

September 14, 2014

News Conference News TCT 2014

PCI for CTO Ups Survival vs. Medical Therapy, CABG

September 14, 2014

Presentation TCT 2014

Complex NonLeft Main Bifurcation #2

Presenter: David E. Kandzari

September 13, 2014

Presentation TCT 2014

The Thoratec PHP

Presenter: Vladimir Dzavik, David R. Holmes Jr., Hiroo Takayama, Kirk N. Garratt, David E. Kandzari

September 13, 2014

Advertisement

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

在SVG PCI中，DES显得安全、有效

Los SLF Parecen Seguros y Efectivos para PCI en IVS

DES Appear Safe and Effective in SVG PCI

得到的FDA专家组支持率低，Watchman可能为时不多了

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

Registry Study: Survival Benefit for Treating CTO After Primary PCI

Registry Study: Survival Benefit for Treating CTO After Primary PCI登记处研究：在首次PCI后治疗CTO可带来生存率益处

Estudio de Registro: Beneficio de Supervivencia para Tratar OTC Post-PCI Primarias

Case Presentation: I Wish I Had Gone Femoral!

Case Presentation: I Wish I Had Gone Radial!

My Worst Radial Case Last Year and What I Learned

My Best Radial Case Last Year and What I Learned

Transradial Primary PCI in STEMI: Benefits, Mechanisms, and Practical Issues

Left Main Coronary Artery Disease: Pathology, Pathophysiology, and Clinical Presentation

TCT 576: Primary Endpoint Results From the PROMUS Element Plus US Postapproval Study (PE-Plus PAS): 1-Year Outcomes in Real-World Patients Treated with a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent

Second Deep Dive into SYMPLICITY HTN-3: Novel Mechanistic Insights from the Trial

PCI for CTO Ups Survival vs. Medical Therapy, CABG

Complex NonLeft Main Bifurcation #2

The Thoratec PHP

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content